|
HY-100131-10mg
|
MedChemexpress LLC
|
GSK481 [CAS 1622849-58-4]
|
|
COVID-19-immunoregulation
|
|
|
HY-100131-100mg
|
MedChemexpress LLC
|
GSK481 [CAS 1622849-58-4]
|
|
COVID-19-immunoregulation
|
|
|
HY-100131-2mg
|
MedChemexpress LLC
|
GSK481 [CAS 1622849-58-4]
|
|
COVID-19-immunoregulation
|
|
|
HY-100131-5mg
|
MedChemexpress LLC
|
GSK481 [CAS 1622849-58-4]
|
|
COVID-19-immunoregulation
|
|
|
HY-100131-50mg
|
MedChemexpress LLC
|
GSK481 [CAS 1622849-58-4]
|
|
COVID-19-immunoregulation
|
|
|
HY-10037-10mg
|
MedChemexpress LLC
|
Quiflapon [CAS 136668-42-3]
|
|
COVID-19-immunoregulation
|
|
|
HY-10037-100mg
|
MedChemexpress LLC
|
Quiflapon [CAS 136668-42-3]
|
|
COVID-19-immunoregulation
|
|
|
HY-10037-5mg
|
MedChemexpress LLC
|
Quiflapon [CAS 136668-42-3]
|
|
COVID-19-immunoregulation
|
|
|
HY-10037-50mg
|
MedChemexpress LLC
|
Quiflapon [CAS 136668-42-3]
|
|
COVID-19-immunoregulation
|
|
|
HY-10209-10mg
|
MedChemexpress LLC
|
Masitinib [CAS 790299-79-5]
|
|
Cancer-Kinase/protease
|
|
|
HY-10209-100mg
|
MedChemexpress LLC
|
Masitinib [CAS 790299-79-5]
|
|
Cancer-Kinase/protease
|
|
|
HY-10209-200mg
|
MedChemexpress LLC
|
Masitinib [CAS 790299-79-5]
|
|
Cancer-Kinase/protease
|
|
|
HY-10209-5mg
|
MedChemexpress LLC
|
Masitinib [CAS 790299-79-5]
|
|
Cancer-Kinase/protease
|
|
|
HY-10209-50mg
|
MedChemexpress LLC
|
Masitinib [CAS 790299-79-5]
|
|
Cancer-Kinase/protease
|
|
|
HY-10209A-10mg
|
MedChemexpress LLC
|
Masitinib (mesylate) [CAS 1048007-93-7]
|
|
Cancer-Kinase/protease
|
|
|
HY-10209A-100mg
|
MedChemexpress LLC
|
Masitinib (mesylate) [CAS 1048007-93-7]
|
|
Cancer-Kinase/protease
|
|
|
HY-10209A-200mg
|
MedChemexpress LLC
|
Masitinib (mesylate) [CAS 1048007-93-7]
|
|
Cancer-Kinase/protease
|
|
|
HY-10209A-5mg
|
MedChemexpress LLC
|
Masitinib (mesylate) [CAS 1048007-93-7]
|
|
Cancer-Kinase/protease
|
|
|
HY-10209A-50mg
|
MedChemexpress LLC
|
Masitinib (mesylate) [CAS 1048007-93-7]
|
|
Cancer-Kinase/protease
|
|
|
HY-103428-10mg
|
MedChemexpress LLC
|
LE 300 [CAS 274694-98-3]
|
|
Neuroscience-Neuromodulation
|
|
|
HY-108713-10mg
|
MedChemexpress LLC
|
Famitinib [CAS 1044040-56-3]
|
|
Cancer-Kinase/protease
|
|
|
HY-108713-100mg
|
MedChemexpress LLC
|
Famitinib [CAS 1044040-56-3]
|
|
Cancer-Kinase/protease
|
|
|
HY-108713-25mg
|
MedChemexpress LLC
|
Famitinib [CAS 1044040-56-3]
|
|
Cancer-Kinase/protease
|
|
|
HY-108713-5mg
|
MedChemexpress LLC
|
Famitinib [CAS 1044040-56-3]
|
|
Cancer-Kinase/protease
|
|
|
HY-108713-50mg
|
MedChemexpress LLC
|
Famitinib [CAS 1044040-56-3]
|
|
Cancer-Kinase/protease
|
|
